TABLE 1.
Characteristics of Patients Undergoing MI-PD From 2014 to 2019
| n (%)/Median (IQR) |
P | ||
|---|---|---|---|
| Robotic (N = 885) | Laparoscopic (N = 655) | ||
|
| |||
| Age (y) | 67 (59, 73) | 65 (57, 72) | 0.045 |
| Sex | 0.764 | ||
| Male | 462 (52.2) | 347 (53.0) | |
| Female | 423 (47.8) | 308 (47.0) | |
| Race | < 0.001 | ||
| White | 729 (82.4) | 469 (71.6) | |
| African American | 69 (7.8) | 57 (8.7) | |
| Other | 87 (9.8) | 129 (19.7) | |
| BMI | 27.1 (23.7, 31.1) | 26.95 (23.7, 30.4) | 0.363 |
| Jaundice | 310 (35.0) | 237 (36.2) | 0.83 |
| Biliary stenting | 462 (52.2) | 300 (45.8) | 0.013 |
| ASA | 0.112 | ||
| I | 2 (0.2) | 5 (0.8) | |
| II | 211 (23.8) | 174 (26.6) | |
| III | 641 (72.4) | 445 (67.9) | |
| IV | 31 (3.5) | 31 (4.7) | |
| Neoadjuvant chemotherapy | 217 (24.5) | 114 (17.4) | 0.001 |
| Neoadjuvant radiotherapy | 30 (3.4) | 51 (7.8) | 0.001 |
| Pancreatic duct size | < 0.001 | ||
| < 3 mm | 295 (33.3) | 161 (24.6) | |
| > 3 mm | 485 (54.8) | 314 (47.9) | |
| Unknown | 105 (11.9) | 180 (27.5) | |
| Pancreatic gland | < 0.001 | ||
| texture | |||
| Soft | 427 (48.2) | 204 (31.1) | |
| Hard | 328 (37.1) | 252 (38.5) | |
| Unknown | 130 (14.7) | 199 (30.4) | |
| Vessel resection | < 0.001 | ||
| None | 792 (89.5) | 524 (80.0) | |
| Vein | 54 (6.1) | 79 (12.1) | |
| Artery | 11 (1.2) | 19 (2.9) | |
| Both | 18 (2.0) | 19 (2.9) | |
| Unknown | 10 (1.1) | 14 (2.1) | |
| Histology | 0.809 | ||
| Malignant | 699 (79.0) | 514 (78.5) | |
| Benign | 186 (21.0) | 141 (21.5) | |
| Malignant histology | 0.632 | ||
| PDAC | 449 (64.2) | 337 (65.6) | |
| Non-PDAC | 250 (35.8) | 177 (34.4) | |
ASA indicates American Society of Anesthesiology; BMI, body mass index; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; PDAC, pancreatic ductal adenocarcinoma.